Insights

Alireza Atri, MD, PhD, discusses the many methods of testing and forming a diagnosis for patients with Alzheimer’s disease, highlighting the recent FDA approval of aducanumab and its impact.

Jeffrey L. Cummings, MD, ScD, discusses the Alzheimer’s disease and the advances recently made to improve the treatment landscape, specifically with aducanumab.

David Kudrow, MD, provides a discussion on the available treatment options for migraine management and prevention.

Elizabeth Thiele, MD, PhD, and Elaine C. Wirrell, MD, discuss the rare pediatric epilepsy conditions Dravet syndrome and Lennox-Gastaut syndrome, from prevalence to the approval of new therapies.

Expert neurologist and sleep specialist Chris Winter, MD, provides practical perspectives on the identification and management of narcolepsy and excessive daytime sleepiness.

Insight from expert neurologist Peter A. LeWitt, MD, who reviews available on-demand therapies for patients with Parkinson’s disease experiencing morning OFF episodes.

Expert neurologists discuss patient cases involving the treatment of adult-onset spinal muscular atrophy (SMA).

Joseph Sullivan, MD, and Elaine C. Wirrell, MD, discuss the diagnosis, management, and treatment of Dravet Syndrome.

John Brandsema, MD, and Julie Parsons, MD, review the diagnosis and optimal management of spinal muscular atrophy.

Experts in the diagnosis and treatment of Alzheimer disease discuss the recent approval of aducanumab, its implications on the field, and other promising therapies and diagnostic technologies in development.